These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4700003)
21. [Clinical significance of disorders of drug kinetics in liver diseases]. Bolanowski M; Orzechowska-Juzwenko K Pol Arch Med Wewn; 1986 Apr; 75(4):288-96. PubMed ID: 3540881 [No Abstract] [Full Text] [Related]
22. Pharmacokinetics of drug interactions. Kedderis GL Adv Pharmacol; 1997; 43():189-203. PubMed ID: 9342177 [No Abstract] [Full Text] [Related]
23. [Clinico-pharmacological aspects of enzyme induction]. Bartłomowicz B Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1430-3. PubMed ID: 3913943 [No Abstract] [Full Text] [Related]
31. [Metabolism of drugs in the liver and disease]. Sonne J; Døssing M; Loft S Ugeskr Laeger; 1988 Jan; 150(4):204-9. PubMed ID: 3376323 [No Abstract] [Full Text] [Related]
32. [Effects of liver disease on drug pharmacokinetics]. Su CY Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457 [No Abstract] [Full Text] [Related]
33. [Influence of disease on the metabolism and effects of drugs in man]. Lavigne JG Union Med Can; 1980 Dec; 109(12):1718-22. PubMed ID: 7210314 [No Abstract] [Full Text] [Related]
34. Prescribing in liver disease. Pearson R Practitioner; 1990 Apr; 234(1487):430-2. PubMed ID: 2367302 [No Abstract] [Full Text] [Related]
35. The effect of hepatic metabolism on the production and toxicity of reactive metabolites in extrahepatic organs. Boyd MR; Statham CN Drug Metab Rev; 1983; 14(1):35-47. PubMed ID: 6839941 [No Abstract] [Full Text] [Related]
36. Drug disposition in liver disease. Shand DG N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536 [No Abstract] [Full Text] [Related]
37. Biotransformation in the liver: implications for human disease. Marver HS; Schmid R Gastroenterology; 1968 Aug; 55(2):282-9. PubMed ID: 4174553 [No Abstract] [Full Text] [Related]
38. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy]. Danysz A Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977 [No Abstract] [Full Text] [Related]
39. Metabolic capabilities of the human fetus: drug biotransformation. Juchau MR Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372 [No Abstract] [Full Text] [Related]
40. [Hepatic enzyme induction and drug effects]. Paumgartner G Ther Umsch; 1971 Apr; 28(4):234-40. PubMed ID: 5575081 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]